Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

Core Insights - Weight Watchers has expanded its collaboration with Novo Nordisk, allowing eligible Med+ members to save up to $1,200 annually on Wegovy® through a new subscription pricing model [1][2][4] Group 1: Subscription Pricing Model - The new subscription offer provides the lowest self-pay price for Wegovy, saving cash-pay members up to $1,200 per year [2] - Eligible Med+ members can pre-pay for three, six, or 12 months of Wegovy at discounted rates, saving up to $100 per month on pens and up to $50 per month on pills compared to standard prices [3][4] - Members can also access limited-time pricing offers, such as starting doses of the Wegovy pill for $149 per month, ensuring competitive pricing for self-pay Wegovy [3] Group 2: Commitment to Health - Both Weight Watchers and Novo Nordisk are dedicated to helping individuals manage obesity, with the subscription pricing aimed at increasing access to treatment [3][4] - Weight Watchers emphasizes that their lifestyle support system can drive 29% greater weight loss compared to medication alone, enhancing the effectiveness of GLP-1 treatments [4][7] - The collaboration reflects a shared commitment to improving access to FDA-approved weight health treatments [4][7] Group 3: Growth and Demand - Weight Watchers' clinical business is experiencing rapid growth, indicating a rising demand for integrated GLP-1 models as consumers seek comprehensive weight health solutions [6] - The company continues to focus on pairing FDA-approved treatments with structured nutritional and lifestyle support to achieve lasting results [7]